GR851291B - - Google Patents

Info

Publication number
GR851291B
GR851291B GR851291A GR850101291A GR851291B GR 851291 B GR851291 B GR 851291B GR 851291 A GR851291 A GR 851291A GR 850101291 A GR850101291 A GR 850101291A GR 851291 B GR851291 B GR 851291B
Authority
GR
Greece
Prior art keywords
sequences
incorporated
give
gene
hybrid
Prior art date
Application number
GR851291A
Other languages
English (en)
Inventor
Joachim Dr Engels
Eugen Dr Uhlmann
Friedrich Dr Wengenmayer
Hubert Dr Mullner
Ernst Ludwig Prof Dr Winnacker
Roland Dr Mertz
Hiroshi Dr Okazaki
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR851291B publication Critical patent/GR851291B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GR851291A 1984-05-29 1985-05-27 GR851291B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843419995 DE3419995A1 (de) 1984-05-29 1984-05-29 Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens

Publications (1)

Publication Number Publication Date
GR851291B true GR851291B (el) 1985-11-25

Family

ID=6237111

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851291A GR851291B (el) 1984-05-29 1985-05-27

Country Status (11)

Country Link
EP (1) EP0163249B1 (el)
JP (1) JPS6199A (el)
AT (1) ATE65797T1 (el)
AU (1) AU589896B2 (el)
DE (2) DE3419995A1 (el)
DK (1) DK166681B1 (el)
ES (1) ES8605813A1 (el)
GR (1) GR851291B (el)
IE (1) IE57996B1 (el)
PT (1) PT80542B (el)
ZA (1) ZA854031B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340853C (en) * 1983-12-23 1999-12-21 Hsiang-Fu Kung Purification of recombinant interleukin-2
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
DE3537461A1 (de) * 1985-10-22 1987-04-23 Hoechst Ag Derivat des interleukin-2, seine herstellung und verwendung
US5496924A (en) * 1985-11-27 1996-03-05 Hoechst Aktiengesellschaft Fusion protein comprising an interleukin-2 fragment ballast portion
DE3712985A1 (de) * 1987-04-16 1988-11-03 Hoechst Ag Bifunktionelle proteine
JPS62185098A (ja) * 1986-02-10 1987-08-13 Otsuka Pharmaceut Co Ltd インタ−ロイキン−２活性を有するポリペプチド
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
FR2643646B1 (fr) * 1989-02-27 1993-09-17 Pasteur Institut Expression de sequences de nucleotides codant pour des vesicules a gaz
US6008319A (en) 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
US6955807B1 (en) 1998-05-15 2005-10-18 Bayer Pharmaceuticals Corporation IL-2 selective agonists and antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483592A1 (fr) * 1980-06-02 1981-12-04 Stein Industrie Dispositif de reduction des contraintes thermiques sur un echangeur de chaleur
US4738927A (en) * 1982-03-31 1988-04-19 Ajinomoto Co. Inc. Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the said gene, a living cell line possessing the recombinant DNA, and method for producing interleukin-2 using the said cell
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
EP0163603B1 (en) * 1984-05-08 1989-12-13 Genetics Institute, Inc. A human t-cell growth factor

Also Published As

Publication number Publication date
ATE65797T1 (de) 1991-08-15
AU589896B2 (en) 1989-10-26
DE3419995A1 (de) 1985-12-05
EP0163249B1 (de) 1991-07-31
PT80542B (pt) 1987-09-30
DE3583634D1 (de) 1991-09-05
ES8605813A1 (es) 1986-01-16
EP0163249A2 (de) 1985-12-04
AU4307085A (en) 1985-12-05
DK237985A (da) 1985-11-30
DK237985D0 (da) 1985-05-28
PT80542A (de) 1985-06-01
IE57996B1 (en) 1993-06-02
ES543508A0 (es) 1986-01-16
EP0163249A3 (en) 1988-05-11
IE851319L (en) 1985-11-29
DK166681B1 (da) 1993-06-28
JPS6199A (ja) 1986-01-06
ZA854031B (en) 1986-01-29

Similar Documents

Publication Publication Date Title
GR851962B (el)
GR851291B (el)
NO172646C (no) Dna-sekvens, repliserbart ekspresjonsplasmid, samt fremstilling av insulin og human-insulin-forloepere
EP0174367A4 (en) HOSTS AND METHODS FOR PRODUCING RECOMBINANT PRODUCTS IN LARGE QUANTITIES.
HUT37815A (en) Process for production of human polipeptids having gamma-interferon activity
ES8603571A1 (es) Un procedimiento para preparar gamma-interferon de humano
ATE90386T1 (de) Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.
IE872531L (en) Preparation of salmon calcitonin by genetic engineering, and¹means for carrying out this process
ES8602933A1 (es) Un metodo para clonar por tecnicas de dna recombinante penicilinacilasas e incrementar su produccion por fermentacion